Latest Industry Projects

Merck Serono invests €80 million for pharma manufacturing in Nantong, China

Merck Serono invests €80 million for pharma manufacturing in Nantong, China

Introduction :

Merck Serono the biopharmaceutical division of Merck, Headquartered in Germany, announced groundbreaking of new Pharmaceutical manufacturing plant in Nantong with an investment of € 80 million.The construction of the site is scheduled to be completed in 2016. Commercial production will begin in 2017.

Features :

The new facility will spread across 40,000 square meters, and probably 20,000 square meters extension. The facility  will focus on the bulk production and packaging of Glucophage®, Concor® and Euthyrox® used in the treatment of diabetes, cardiovascular diseases and thyroid disorders, respectively.

Plant is designed to meet international standards especially with respect to quality, environment, health and safety.


Specifications

Company Name           :         Merck Serono
Location                      :         Nantong Economical Technological Development Area (NETDA), Shanghai region
Construction Type        :         New Construction
Project Starting Year    :         August 2014
Year of Completion       :         2016
Estimated Cost            :         € 80 million

Other Projects